Stereotaxis, Inc.

We inadvertently omitted the disclosure of a Rule 10b5-1 Plan adopted by Kimberly Peery, our CFO, in September, 2025 in Item 5 of Part II in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. In September 2025, Ms. Kimberly Peery, the Chief Financial Officer of the Company, adopted a trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Peery’s Rule 10b5-1 Trading Plan, which has a term of one year, provides for the exercise and sale of up to 204,750 incentive stock options pursuant to the limit orders specified in the plan. The plan will be effective for 12 months following the 90-day cooling off period. The adopted plan replaced Ms. Peery’s prior plan which had a one-year term and was adopted on September 1, 2024.